Our RAP Platform™ is enabling the discovery and development of potential therapies for a broad spectrum of diseases. Using this pioneering approach, we can generate therapeutic candidates capable of specific, tunable and durable mRNA amplification.
With the right approach, scaling any mountain is achievable.
We are developing a pipeline of RNA Actuator therapeutic candidates with the potential to open up vast new horizons for patients. We are exploring RNA Actuators in multiple indications with genetically validated targets, with an initial focus on metabolic and central nervous system diseases.
Expansion areas: skeletal muscle, heart, and the immune system.